Satterley & Kelley PLLC

Get A Free Consultation

855-385-9532

  • Home
  • About
  • Practice Areas
    • Asbestos-Mesothelioma
      • Asbestos Products
      • Cosmetic Talcum Powder
      • Household Exposure To Asbestos
      • Mechanic And Auto Worker Exposure
      • Mesothelioma Symptoms And Diagnosis
      • Mesothelioma Treatment Options
      • Phenolic Molding Compounds
      • Toxic Torts
      • Winning Verdicts
    • Personal Injury
      • Slip And Falls
      • Wrongful Death
      • Nursing Home Neglect And Abuse
      • Dog Bites
      • Injured Railroad Employees
      • House Explosions
      • Premises Liability
      • Product Liability
      • Liquor Liability & Dram Shop
      • Negligent Security
    • Car Accidents
      • Car Accident FAQ
      • Distracted Driving Accidents
      • Drunk Driving Accidents
      • Motorcycle Accidents
      • Truck Accidents
      • Pedestrian Accidents
      • Bicycle Accidents
      • Dram Shop Law In Kentucky
      • Teenage Drivers: A Likely Safety Risk
      • Uninsured/Underinsured Motorist Collisions
  • Video Center
  • Verdicts & Settlements
  • Referrals
  • Resources
    • Blog
    • Articles and FAQ’s
      • What is Asbestos?
      • What Causes Mesothelioma?
      • Mesothelioma symptoms
      • How is Mesothelioma Diagnosed?
      • What are Mesothelioma Stages?
      • What are the Types of Mesothelioma?
      • Mesothelioma Survival Rates
      • Mesothelioma Treatment
      • Palliative Care for Mesothelioma
    • Infographics
  • Contact Us
  • Menu Menu

You Do Not Have to Stand Alone

Know Your Rights. Call 855-385-9532 For A Free Initial Consultation

Defactinib ineffective for malignant pleural mesothelioma

June 20, 2019/0 Comments/in Mesothelioma

A COMMAND Phase 2 trial of maintenance therapy using the drug defactinib has been found unable to increase the survival rate of patients with malignant pleural mesothelioma. This aggressive and incurable cancer has few treatment options to begin with; Louisville residents should know that the primary treatment is chemotherapy using a combination of the drugs pemetrexed and cisplatin.

This, in itself, has limited results, and no approved therapy exists for addressing the cancer as it begins to progress. Researchers tested defactinib in 344 patients who had undergone at least four cycles of chemotherapy. A random selection of 173 patients received oral defactinib while the rest were given a placebo. For the first group, 4.1 months was the median progression-free survival: in other words, the time between treatment and the first signs that the condition is worsening. For the second group, that number was 4 months.

There was also little difference between the two groups regarding survival rate and quality of life. Mesothelioma progression was the reason why therapy was ultimately discontinued for 62% of the patients.

Researchers had hoped that defactinib maintenance therapy would provide patients with a new and targeted therapy for their cancer. According to researchers, the benefits of precision medicine are underexplored when it comes to the treatment of pleural mesothelioma.

Mesothelioma is a cancer usually linked with long-term asbestos exposure. Victims may be exposed to this mineral through products like automotive parts and even cosmetic products, or they may breathe it in while working in buildings with old insulation or tiles containing asbestos. Whatever the situation, victims are normally not to blame, but someone else might be, such as an employer or the manufacturer of a contaminated product. Those who wish to pursue a claim and recover damages may consult with a lawyer.

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
/wp-content/uploads/2020/01/logo.png 0 0 competenow /wp-content/uploads/2020/01/logo.png competenow2019-06-20 00:00:002022-11-10 02:05:18Defactinib ineffective for malignant pleural mesothelioma
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search Our Site

Recent Posts

  • Legal Discovery and Mesothelioma Lawsuits
  • Unique Rules for Pursuing Asbestos Claims Against Employers in PA (Podcast)
  • What is Product Liability?
  • Dram Shop Law and Liability (Podcast)
  • The Dangers of Asbestos and the Cover Up

Categories

  • Asbestos (51)
  • Car Accidents (64)
  • Distracted driving (4)
  • Dog Bites (2)
  • Firm News (8)
  • Gas Explosions (1)
  • Injuries (1)
  • Mesothelioma (98)
  • Motorcycle Accidents (5)
  • Nursing Home Negligence (3)
  • Personal Injury (11)
  • Premises Liability (10)
  • Railroad Accidents (3)
  • Truck Accidents (12)
  • Uncategorized (27)
  • Wrongful Death (2)

Archives

KY Asbestos Exposure White Paper
Super Lawyers Badge
American Association for Justice Badge
Kentucky Bar Association Badge
Kentucky Justice Association Badge
American Bar Association Badge

You do not have to stand alone. Call 855-385-9532 to talk to a lawyer at Satterley & Kelley PLLC in Louisville.

Get Help Now

"*" indicates required fields

Disclaimer | Privacy Policy

Disclaimer*

Office Address

8700 Westport Road
Suite 202
Louisville, KY 40242

Louisville Law Office Map

855-385-9532

Fax: 502-814-5500

  • Link to Facebook
  • Link to Twitter
  • Link to LinkedIn
Review Us

© 2022 Satterley & Kelley PLLC • All Rights Reserved

Disclaimer | Site Map | Privacy Policy